Compare LSBK & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSBK | ORMP |
|---|---|---|
| Founded | 1891 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.0M | 117.8M |
| IPO Year | 2006 | N/A |
| Metric | LSBK | ORMP |
|---|---|---|
| Price | $14.97 | $2.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.3K | ★ 165.3K |
| Earning Date | 01-23-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.42% | N/A |
| EPS Growth | 105.28 | ★ 838.25 |
| EPS | ★ 1.21 | 1.03 |
| Revenue | ★ $27,774,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.34 | ★ $2.74 |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $11.50 | $1.82 |
| 52 Week High | $16.95 | $3.24 |
| Indicator | LSBK | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 51.93 |
| Support Level | $14.53 | $2.83 |
| Resistance Level | $14.98 | $3.24 |
| Average True Range (ATR) | 0.21 | 0.16 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 40.91 | 24.37 |
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.